导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.14% | 789/950 |
| 近一周 | 3.08% | 303/956 |
| 近一月 | 2.85% | 895/954 |
| 近一季 | -9.43% | 837/943 |
| 近半年 | -4.05% | 325/910 |
| 近一年 | -27.55% | 790/859 |
| 近两年 | -20.00% | 498/746 |
| 近三年 | -19.55% | 257/558 |
| 成立以来 | 48.12% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2023 | -19.76% 665/952 |
0.65% 599/880 |
-13.07% 830/895 |
-9.52% 570/915 |
1.36% 82/952 |
| 2022 | -14.35% 158/867 |
-13.06% 174/773 |
2.11% 662/806 |
-15.10% 575/845 |
13.63% 46/867 |
| 2021 | 16.44% 180/740 |
-1.61% 208/580 |
22.85% 123/659 |
-0.49% 221/704 |
-3.19% 549/740 |
| 2020 | 81.98% 85/554 |
12.74% 32/419 |
40.59% 21/466 |
8.40% 294/517 |
5.91% 421/554 |
| 2019 | 36.22% 252/410 |
24.30% 760/1149 |
-2.58% 558/1231 |
12.05% 79/390 |
0.40% 385/410 |
| 2018 | -19.34% 64/349 |
- - |
- - |
- - |
-11.54% 482/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实资源精选股票C | 2.9607 | 31.31% |
| 申万菱信量化精选A | 0.6682 | 26.65% |
| 鹏华医药 | 1.1201 | 24.15% |
| 泰达转型C | 2.2130 | 20.03% |
| 华商上游产业 | 2.4892 | 19.74% |
| 嘉实资源精选股票A | 3.0410 | 19.55% |
| 北信瑞丰研究精选 | 1.3995 | 19.25% |
| 嘉实价值精选股票 | 2.1217 | 18.27% |
| 广发资源优选股票 | 1.7312 | 16.87% |
| 科创红土 | 0.8817 | 16.78% |
| 建信高端医疗股票 VS. 前海开源公用事业股票(005669) |
| 建信高端医疗股票 VS. () |